Important OptumRx updates to support providers, clinical staff and patients through COVID-19.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 17, 2020 - The drug shortage of Hospira’s nalbuphine injection is ongoing. Nalbuphine has been unavailable for at least 90 days due to a shortage of an active ingredient.
Return to publications